Consistent with increased access of these pro‐inflammatory factors, serum levels of IL‐1β, TNF‐α and IL‐6 were elevated in DSS‐treated mice, which were drastically reduced in mice colitis model following CHC treatment (Figure 4C). The gene discussed is IL6; the disease is colitis.